Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,828 | 103 | 99.4% |
| Education | $11.56 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $381.49 | 21 | $0 (2024) |
| Lilly USA, LLC | $277.01 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $238.29 | 15 | $0 (2024) |
| PFIZER INC. | $212.05 | 13 | $0 (2024) |
| Abbott Laboratories | $104.69 | 6 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $67.46 | 3 | $0 (2024) |
| ABBVIE INC. | $54.68 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $51.60 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $51.22 | 2 | $0 (2024) |
| Exact Sciences Corporation | $44.25 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $955.97 | 54 | Novo Nordisk Inc ($187.16) |
| 2023 | $620.64 | 36 | Novo Nordisk Inc ($135.79) |
| 2022 | $214.12 | 11 | Novo Nordisk Inc ($58.54) |
| 2021 | $26.26 | 2 | GlaxoSmithKline, LLC. ($14.70) |
| 2019 | $22.58 | 1 | SANOFI PASTEUR INC. ($22.58) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/27/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.77 | General |
| 10/14/2024 | Merck Sharp & Dohme LLC | VAXELIS (Biological), CAPVAXIVE | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: VACCINE | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: PAIN | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 426 | 949 | $164,203 | $60,638 |
| 2022 | 8 | 441 | 879 | $149,138 | $58,652 |
| 2021 | 6 | 364 | 850 | $139,797 | $63,315 |
| 2020 | 6 | 408 | 849 | $103,279 | $41,172 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 712 | $125,312 | $45,618 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 71 | $13,561 | $7,207 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 101 | $13,635 | $4,178 | 30.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $5,740 | $2,042 | 35.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,355 | $1,226 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $927.00 | $216.96 | 23.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 26 | 28 | $1,673 | $149.52 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 576 | $101,376 | $37,280 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 72 | $13,752 | $7,720 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 127 | $15,418 | $6,048 | 39.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $8,034 | $4,268 | 53.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 15 | $6,150 | $2,262 | 36.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 14 | 18 | $1,440 | $468.08 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 16 | $1,236 | $440.00 | 35.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 29 | 29 | $1,732 | $167.00 | 9.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 614 | $98,470 | $43,183 | 43.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 71 | $14,326 | $7,819 | 54.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 99 | $9,998 | $4,619 | 46.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 25 | 26 | $9,628 | $4,270 | 44.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $6,180 | $3,293 | 53.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 20 | 20 | $1,195 | $131.00 | 11.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 190 | 510 | $70,227 | $27,303 | 38.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 131 | 228 | $20,426 | $7,775 | 38.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 16 | 22 | $7,634 | $3,036 | 39.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 43 | 61 | $3,172 | $2,276 | 71.8% |
About Dr. Keith Marshall, MD
Dr. Keith Marshall, MD is a Family Medicine healthcare provider based in Verona, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1770804288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Marshall, MD has received a total of $1,840 in payments from pharmaceutical and medical device companies, with $955.97 received in 2024. These payments were reported across 104 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,828).
As a Medicare-enrolled provider, Marshall has provided services to 1,639 Medicare beneficiaries, totaling 3,527 services with total Medicare billing of $223,777. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Verona, NY
- Active Since 06/18/2010
- Last Updated 11/21/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1770804288
Products in Payments
- MOUNJARO (Drug) $190.20
- TRELEGY ELLIPTA (Drug) $171.97
- Rybelsus (Drug) $163.90
- Ozempic (Drug) $128.74
- FREESTYLE LIBRE 2 (Device) $104.69
- NURTEC ODT (Drug) $77.98
- Wegovy (Drug) $74.66
- KEVEYIS (Drug) $67.46
- ELIQUIS (Drug) $65.66
- PAXLOVID (Drug) $55.43
- SHINGRIX (Biological) $53.33
- PREVNAR 20 (Biological) $48.53
- Cologuard Collection Kit (Device) $44.25
- INSPIRE (Device) $40.37
- QUVIVIQ (Drug) $40.10
- FARXIGA (Drug) $40.04
- EMGALITY (Drug) $37.86
- UBRELVY (Drug) $36.88
- Otezla (Drug) $36.12
- GARDASIL (Biological) $31.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Verona
Dr. Sally Mravcak, M.d, M.D
Family Medicine — Payments: $53,728
Ngoc Le, D.o, D.O
Family Medicine — Payments: $2,670
Everett Schlam, Md, MD
Family Medicine — Payments: $1,913
Dr. Valery Vera-Connolly, M.d, M.D
Family Medicine — Payments: $1,680
Dr. Kennedy Daftani, M.d, Mhsa, M.D, MHSA
Family Medicine — Payments: $942.18
Mrs. Diane Landauer, M.d, M.D
Family Medicine — Payments: $879.22